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ABSTRACT
ST1710, a member of the multiple antibiotic resis-
tance regulator (MarR) family of regulatory proteins
in bacteria and archaea, plays important roles
in development of antibiotic resistance, a global
health problem. Here, we present the crystal struc-
ture of ST1710 from Sulfolobus tokodaii strain 7
complexed with salicylate, a well-known inhibitor
of MarR proteins and the ST1710 complex with its
promoter DNA, refined to 1.8 and 2.10A ˚ resolutions,
respectively. The ST1710–DNA complex shares the
topology of apo-ST1710 and MarR proteins, with
each subunit containing a winged helix-turn-helix
(wHtH) DNA binding motif. Significantly large con-
formational changes occurred upon DNA binding
and in each of the dimeric monomers in the asym-
metric unit of the ST1710–DNA complex. Conserved
wHtH loop residues interacting with the bound
DNA and mutagenic analysis indicated that R89,
R90 and K91 were important for DNA recognition.
Significantly, the bound DNA exhibited a new bind-
ing mechanism.
INTRODUCTION
Microbial antibiotic resistance is a result of either inacti-
vation or reduced accumulation of antibiotics within an
organism. Proteins belonging to the multiple antibiotic
resistance regulators (MarR) family reportedly regulate
the expression of proteins conferring resistance to multiple
antibiotics, organic solvents, household disinfectants,
oxidative stress agents and pathogenic factors (1–3). For
example, in the absence of the appropriate stimulus,
Escherichia coli MarR proteins negatively regulate the
marRAB operon, and repression of this operon is alle-
viated by exposure to a variety of phenolic compounds,
most notably sodium salicylate (1). Similarly, MexR neg-
atively regulates an operon in Pseudomonas aeruginosa
that, when expressed, encodes a tri-partite multi-drug
eﬄux system that results in an increased resistance to
multiple antibiotics, including tetracycline, b-lactams,
chloramphenicol, novobiocin, trimethoprim, sulfonamides
and ﬂuoroquinolones (4,5). Some members of the MarR
family of DNA-binding proteins, for example hypotheti-
cal uricase regulator (HucR) and organic hydroperoxide
resistance regulator (OhrR), mediate a cellular response to
reactive oxidative stress (ROS) (6,7). The Deinococcus
radiodurans HucR was shown to repress its own expres-
sion as well as that of an uricase. This repression is alle-
viated both in vivo and in vitro upon binding uric acid, the
substrate for uricase. As uric acid is a potent scavenger of
reactive oxygen species, and D. radiodurans is known for
its remarkable resistance to DNA-damaging agents, these
observations indicate a novel oxidative stress response
mechanism (8–10). Similar to HucR, the OhrR protein
of Bacillus subtilis also mediates a response to oxidative
stress; however, for OhrR, it is oxidation of a lone cysteine
residue by organic hydroperoxides that abrogates DNA
binding (11,12).
We have reported two diﬀerent crystal forms of ST1710
(13) and others (14). The structure showed the winged
helix-turn-helix (wHtH) motif at the DNA binding site
that obviously belonged to the MarR family of proteins.
The crystal structures of proteins in the MarR family have
also been determined from a number of organisms includ-
ing MarR from E. coli (15), MexR from P. aeruginosa
(16), SarR from Staphylococcus aureus (17), Slya-like pro-
tein from Enterococcus faecalis (18), OhrR from B. subtilis
(19), HucR from D. radiodurans (20) and MTH313 from
Methanobacterium thermoautotrophicum (21). Sequence
comparisons of these proteins with ST1710 showed less
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dant protein database using Blastp revealed that ST1710
has about 51% identity to the Sulfolobus acidocaldarius
(22) and Sulfolobus solfataricus (23) sequences and about
41% identity to the Metallosphaera sedula sequence (24).
However, none of the proteins closely related to ST1710
have been biochemically or structurally characterized.
Sodium salicylate is well known to inhibit MarR activ-
ity both in vitro and in vivo, at millimolar concentration
levels (25). Sodium salicylate is routinely used as a model
inhibitor of MarR to induce MarA expression in E. coli
and Salmonella typhimurium, thereby conferring a Mar
phenotype (25–28). The structure of E. coli MarR was
solved with two salicylate molecules per monomer and
both of them are highly exposed to the solvent. It seems
that salicylate may have stabilized the crystal packing
since in the absence of salicylate, the crystals could not
be used for structure determination in the case of E. coli
MarR (15). Recently, the structure of MTH313, a MarR
homolog from M. thermoautotrophicum, was solved in the
free form and complexed with salicylate; these analyses
revealed a large asymmetrical conformational change
that is mediated by the binding of sodium salicylate to
two distinct locations in the dimer (21).
The members of the MarR family of regulatory proteins
recognize double stranded DNA by their wHtH motifs
(15–19). Footprinting experiments revealed that MarR
binds as a dimer at two diﬀerent, but similar, sites in
marO, protecting 21bp of DNA on both strands at a
single site without bending its target (29,30). One of the
MarR families of proteins, the OhrR protein complexed
with the ohrA operator with a 29-bp duplex was solved,
which revealed the interactions between them. The
protein–DNA contact region included the major groove
of the  10 element, and indicated that OhrR, and proba-
bly MarR and MexR as well, repress transcription by
blocking the access of RNA polymerase to this promoter
element (19). In addition, the mutational analysis of the
RNA polymerase binding site, the  10 element of the
OhrR-, MarR- and MexR-regulated promoters, revealed
the loss of DNA binding ability by  10-fold when this
region was altered (11,16,30,31).
On the basis of the sequence of the ohrA promoter, we
previously identiﬁed a putative promoter for ST1710 and
showed binding ability by gel-mobility shift assays (13).
This promoter is located immediately upstream of the ﬁrst
ATG of the ST1710 gene and downstream of the STS1709
gene. To understand the importance of MarR family
members in antibiotic resistance and other biological pro-
cesses, here, we solved the ST1710 in three diﬀerent forms:
(i) apo-form (native), (ii) complexed with its inhibitor,
sodium salicylate (salicylate complex) and (iii) complexed
with its promoter DNA. A slight conformational change
on the side chains of protein residues’ was observed when
bound to the salicylate ligand, compared to the apo-form.
The DNA bound to the wHtH motif of one monomer on
the dimeric ST1710, and speciﬁcally interacted with the
residues R84, R89, R90 and K91. A signiﬁcantly large
conformational change was observed between the mono-
mers of the dimeric protein bound to the DNA, and also
with the apo/salicylate complex structures. Signiﬁcantly, a
distinct mode of DNA binding was observed with
the bound DNA passing over the protein molecule
rather than passing through the 2-fold related axis of the
molecule as previously observed (19).
MATERIALS AND METHODS
Cloning, expression and purification of ST1710
The gene encoding the MarR family regulator protein
(ST1710) from Sulfolobus tokodaii (S. tokodaii) strain 7
was ampliﬁed from genomic DNA by PCR, using the
primers 50-ggaattCATATGTTAGAAAGTAATGAAAA
CAGAATAC-30 and 50-ggaattGGATCCTTATTACTGA
CTAATTTCCTCAATTCTTTTC-30. The PCR fragment
was digested with NdeI and BamHI and cloned into the
pET21a(+) expression vector. The plasmid was trans-
formed into the E. coli BL21-CodonPlus (DE3)—RIL-X
strain (Stratagene), and the selenomethionine-containing
ST1710 proteins were over-expressed and puriﬁed as
described in our earlier studies (13).
Crystallization and data collection
Native crystals of ST1710 were produced to medium size
(0.1 0.1 0.1mm) within the period of a week at 208C
by the sitting drop vapor diﬀusion method (32), by adding
1ml of protein solution to 1ml of well solution, containing
18% PEG 8K, 0.2M calcium acetate, and 0.1M sodium
cacodylate, pH 6.5. For the ST1710–salicylate complex,
crystals were soaked in the mother liquor containing
0.2M of sodium salicylate for 3min. Twenty percent ethy-
lene glycol was used as a cryo-protectant and the complete
data set was collected for the native and salicylate complex
with the in-house R-axis VII system (RIGAGU MSC).
These crystals belonged to the tetragonal space group,
P41212, and the processed data statistics are given in
Table 1. The 30bp synthetic oligonucleotide containing
the putative promoter sequence (50-AATAATGTCATT
GTTAACAATAGCAAAAAT-30) and its complementary
oligonucleotide (50-ATTTTTGCTATTGTTAACAATG
ACATTATT-30) were annealed completely to form the
DNA-duplex and complexed with the ST1710 protein
at an equimolar ratio. Initial crystals of ST1710–DNA
complex were produced at 208C by the sitting drop
vapor diﬀusion method (32), by adding 1ml of protein–
DNA complex solution to 1ml of well solution, containing
30% (v/v) 2-Methyl-2,4-pentanediol (MPD), 0.02M cal-
cium chloride dehydrate and 0.1M sodium acetate trihy-
drate, pH 3.8. Preliminary tiny crystals that were seeded in
the equilibrated drops of the same condition grew up to a
maximum dimension of 0.3mm within a 2-week period.
Complete Multiple Anomalous Dispersion (MAD) data
sets were obtained at 100K using a Jupiter210 CCD detec-
tor (RIGAGU MSC) on the RIKEN structural genomics
beamline I (BL26B1) at SPring-8, Hyogo, Japan. These
crystals belonged to the centered orthorhombic space
group C2221, with cell dimensions a=94.44, b=106.73
and c=82.26A ˚ . The native and Se-edge MAD data sets
were processed up to 2.10A ˚ using the HKL2000 suite (33)
(Table 1).
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The native and salicylate complex of ST1710 structures
were determined by the molecular replacement method,
using our previous ST1710 structure (PDB code, 2eb7),
as a search model. The solution was found by auto-
mated-MOLREP, within the CCP4 program suite, and
the reﬁnement was carried out using CNS (34). The pro-
tein model was built using the programs Quanta (35) and
Coot (36). The native and salicylate complexes were
reﬁned to resolutions 1.80 and 2.0A ˚ , respectively
(Table 1). Since the molecular replacement method was
not successful for phasing the ST1710–DNA complex,
we collected and processed the Se-MAD data sets. The
ST1710–DNA complex structure was successfully phased
by the MAD method with the three diﬀerent wavelength
data sets collected at the Se-edge, using the program
SOLVE (37). Solvent ﬂattening and initial model building
were performed by RESOLVE (37). Improvement of the
partial model derived from RESOLVE was performed
with the ARP/wARP program (38). We observed unam-
biguous density for the DNA bases and built the DNA-
model using the program Quanta (35). The ﬁnal model
was reﬁned and manually ﬁtted using CNS (33), Coot
(36) and Quanta (34). The ﬁnal model with 285 protein
residues and 23 nucleic acid bases, except for 4 and 3
residues in the N-terminal of A and B chains, respectively,
was reﬁned to a crystallographic R-factor of 0.237
(Rfree=0.287) at 2.10A ˚ resolution, using synchrotron
radiation X-ray data collected at cryo temperature (see
Table 1). Figures were prepared with the program
Pymol (39). The coordinates and structure factors for
the native, salicylate, and ST1710–DNA complex have
been deposited in the Protein Data Bank, under the acces-
sion codes 3GEZ, 3GF2 and 3GFI, respectively.
Differential scanning calorimetric (DSC) analysis of
salicylate binding to ST1710
DSC experiments were carried out using a VP-capillary
DSC platform (Microcal, USA). For the DSC measure-
ments, the protein concentration was ﬁxed at 0.5mg/ml in
20mM Tris–HCl buﬀer (pH 8.0) containing 150mM
NaCl. Dialyzed protein sample and the sodium salicylate
were ﬁltered through a 0.22mM pore size membrane and
complexed with diﬀerent concentrations of sodium salicy-
late (0–300mM) and were loaded on to the capillary
system. The scan rate was 908C/hr for all experiments.
We calculated the binding constant (Kd) of sodium salicy-
late using the DSC curves analysis using the Origin soft-
ware (Microcal, USA) and the Graphpad Prism 2.0, a
non-linear curve-ﬁtting algorithm (GraphPad software).
Site-directed mutagenesis of ST1710 and gel-mobility
shift assays
Initially, the ST1710 plasmid was prepared with a Qiagen
miniprep kit. The Quickchange site-directed mutagenesis
kit (Stratagene) was used to create the DNA-binding site
mutants (R89A, R90A and K91A), and the resultant plas-
mids were transformed into JM109 cells. N-terminal
sequencing was carried out for all the mutants, which
were expressed and puriﬁed in a manner similar to the
native protein (13).
To evaluate the protein–DNA interactions in solution, a
gel-mobility shift assay was used. The puriﬁed ST1710 was
incubated in binding buﬀer (10mM Tris–HCl, pH 8.0,
200mM NaCl, 20mM MgCl2 and 5mM b-ME) at pre-
determined concentrations, and the 30-mer DNA
(100nM) was added. The reaction mixture was incubated
for 20min at room temperature and mixed with 1mlo f
50% glycerol before loading onto the gel. The free DNA
and ST1710–DNA complexes were resolved on a 10%
polyacrylamide gel (running buﬀer, 1X TBE, constant vol-
tage, 200V; temperature, 48C). Inhibition of ST1710 was
analyzed in the presence of increasing concentrations of
sodium salicylate by gel-mobility shift analysis. The free
and complexed nucleic acids were stained by ﬂuorescent
SYBR Green (EMSA Kit, Invitrogen) and the bands
visualized with a UV transilluminator (LAS-3000,
FUJIFILM, Japan).
RESULTS AND DISCUSSION
Biophysical analysis of salicylate binding to ST1710 and
inhibition assays
Previous in vitro and in vivo analyses of MarR fam-
ily of proteins suggested that salicylate is a broad inhibi-
tor for MarR activity at the millimolar concentration
levels (1). To investigate whether salicylate binds to
ST1710, we used a diﬀerential scanning calorimetric
method for the binding analysis. Various concentrations
of sodium salicylate (0–300mM) were mixed with the
protein and the heat capacities (Cp) measured with the
scan rate of 908C/hr (Figure 1A). The binding constant
(Kd) was 20 4.9mM for sodium salicylate as calculated
by the GraphPad Prism software, while the Origin
program produced similar values. This analysis clearly
suggests that salicylate binds to ST1710, and the binding
constants were comparable with other members of MarR
family (21).
Next, to visualize the protein–DNA inhibition by
sodium salicylate, we used the gel-mobility shift assays.
While the ST1710–DNA complex formed more compact
than free DNA alone, the addition of salicylate inhibited
the DNA–protein complex. At concentrations above
100mM, the most of the DNA in the salicylate treated
complex released from ST1710. This analysis clearly
demonstrates that the ST1710–DNA complex formation
was inhibited with increasing concentrations of salicylate
(Figure 1B). Taken together, the data indicates that
salicylate bound to the ST1710 in solution and inhibited
the protein–DNA complex when it exceeded the intracel-
lular concentration levels.
Structure of ST1710 complexed with salicylate
Our DSC and gel-mobility shift analyses conﬁrmed that
salicylate bound to the ST1710 and inhibited the protein–
DNA complex formation. To see how salicylate binds to
ST1710, we determined the ST1710–salicylate complex at
a resolution of 1.80A ˚ , and reﬁned to a ﬁnal R value of
23.3% and an Rfree value of 26.5%. The overall structure
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reported native structure, showing that it belongs to the
a/b family of proteins and resembles those of the MarR
family of proteins. It consists of six a-helices and two
b-strands, arranged in the order of a1-a2-a3-a4-b1-b2-
a5-a6 in the primary structure (Figure 2A). The asymmet-
ric subunit contains one molecule, with overall dimensions
of 60 39 26A ˚ . Two monomers are related by a crystal-
lographic 2-fold axis to form the dimer (Supplementary
Figure S1), and this is consistent with our gel-ﬁltration
analysis (13) as well as with studies of other MarR
family proteins (15–19). The N- and C-terminal equivalent
residues of each monomer, located at the a1, a5 and a6
helices, are closely intertwined and form a dimerization
domain, which is stabilized by hydrophobic and hydrogen
bonding interactions between the residues located within
these regions. Apart from the dimerization domain, as
observed in many DNA binding transcriptional regula-
tors, the residues located at the a2-a3-a4-b1-b2 formed a
wHtH DNA binding motif. In the dimer, the distances
between the recognition helix (a4) to the recognition
helix and the loop to loop (connecting the b-strands) of
the wHtH domains are  30 and  70A ˚ , respectively.
The ﬁne quality of the electron density map allowed us
to identify unambiguously the speciﬁc salicylate binding
site in the complex structure. The bound salicylate is
located at the interface between the helical dimerization
and wHtH DNA-binding domains (Figures 2A and B).
The large portion of the DNA-binding and dimerization
domains formed a salicylate-binding pocket. The salicy-
late ligand has many interactions with the protein residues
(Figure 2B). The O2
0 of salicylate is bonded to the side
chain oxygens of Y37 and Y111; in addition, side chain
oxygen of Y37 is also bonded to the O1
0 of the ligand
molecule. The ligand oxygen O1
0 is hydrogen bonded to
the side chain amino group (NH2) of residue R20, while
the O2 of ligand molecule is hydrogen bonded to the side
chain nitrogen of K17. The latter two interactions are from
the symmetrically related molecule. Thus, the bound sali-
cylate has many interactions. All of the residues which
interact with the ligand are highly conserved among the
closely related species (Figure 1E).
Next, to observe if any conformational change occurred
in the salicylate liganded complex when compared to the
native structure, we collected the new native data set from
the crystal grown under the same conditions, solved
at 2.0A ˚ and reﬁned to a ﬁnal R value of 21.1% and
an Rfree value of 25.2%. The overall conformation of
the complex is very similar to the native structure, with
an rmsd of 0.11A ˚ for superposition of 141 Ca atoms
(Figure 2C). However, a minor conformational change
was observed in the side chain orientations of the ligand
interacting residues and the DNA-binding wHtH motifs.
We believe that allosteric changes might occur at the
molecular level in solutions in the presence of inhibiting
ligand, salicylate, which is not seen in the crystal structure.
A divalent metal ion, Ca
2+, was observed in the native
structure, and it interacted with the C-terminal Q146 and
Figure 1. Salicylate binding and inhibition of ST1710–DNA complex assays. (A) DSC analysis of salicylate binding to ST1710. Typical excess heat
capacity curves of ST1710 in the absence/presence of sodium salicylate ligand, at a scan rate of 908C/hr. Salicylate concentration and peak tem-
perature are noted on each curve. The binding constant was calculated using the non-linear regression ﬁt, using the GraphPad Prism software.
(B) Gel-mobility shift assay showing ST1710–DNA complex inhibition. All reactions were carried out in binding buﬀer containing 150mM of protein
and various amounts of sodium salicylate (to a ﬁnal concentration of 0–250mM; lanes 1–16 with 0, 1, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150,
200 and 250mM, respectively) were added and incubated at room temperature for 20min. To this reaction mixture, 100nM of 30-mer DNA added,
and after for 20min., the reactions were fractionated by 10% native PAGE and the DNA stained by SYBR Green (EMSA Kit, Invitrogen).
The positions of the free and complex DNA are indicated by an arrow and an arrowhead, respectively.
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of the symmetrically related molecule (Figure 2C).
It is interesting to compare the salicylate complexes
within the MarR family of regulators. There are two
complex structures available; MarR from E. coli and
the more recently solved MTH313 from M. thermoauto-
trophicum. Although these proteins displayed sequence
similarity  26% to ST1710, the superposition of the
Figure 2. Structure of ST1710 native and salicylate complex and sequence comparison with closely related proteins. (A) A ribbon diagram of the
ST1710–salicylate complex. The secondary structure assignments and the N-/C- termini are labeled on the structure. The bound salicylate is shown in
the stick model. (B) An electrostatic representation of the ST1710 monomer. The basic regions are shown in blue, and the acidic regions are red.
Close-up view of salicylate binding site interactions with protein residues. The hydrogen bonds are indicated by broken lines. (C) Structural
comparison of the ST1710–salicylate complex with the native structure. The native structure is shown in orange color. The salicylate and key
residues involved in interactions are shown in stick models and the bound Ca
2+ ion in the native structure is represented by an orange sphere. The
Ca
2+ ion binding site is enlarged. (D) Superimposition of the ST1710–salicylate complex along with another known MarR family protein crystallized
with salicylate. The E. coli MarR is represented by blue color and M. thermoautotrophicum MTH313 is shown in red. (E) Sequence analysis of
ST1710 (S. tok) and its closely related proteins from diﬀerent species: S. acidocaldarius (S. aci), S. solfataricus (S. sol), and M. sedula (M. sed) along
with the OhrR protein. Conserved residues are indicated by red letters. The secondary structural elements in the primary sequences of ST1710 are
indicated as a-helices (bars), b-strands (arrows) and loops (lines). The salicylate and DNA contacting residues in ST1710 are shown in blue-shaded
and yellow-shaded boxes, respectively. DNA contacting residues of the wing in OhrR are indicated by red asterisks. Selected homologous/identical
residues that interact with DNA in OhrR are indicated by blue asterisks.
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that the overall topology is similar, with an rmsd of
1.90A ˚ for 119 Ca atoms and 2.1A ˚ for 131 Ca atoms for
E. coli MarR and M. thermoautotrophicum MTH313,
respectively (Figure 2D). However, E. coli MarR was crys-
tallized with two molecules of salicylate per dimer, both of
which were highly exposed to the solvent (15), and these
salicylate binding sites are not comparable to that with
ST1710. The salicylate ligands in MarR hydrogen
bonded to some of the amino acid residues (A70, T72,
R77 and R86); however, the physiological relevance of
either salicylate binding site could not be determined
because the ligands were involved in interactions with pro-
tein molecules within the crystal which may stabilize the
crystal lattice. On the other hand, the mode of salicylate
binding between ST1710 and MTH313 is comparable, and
the ligand adjusted up  2A ˚ and  3A ˚ towards the a5
helix upon binding. In contrast to the salicylate binding
in ST1710, two direct and one water mediated protein
residues were in contact with the ligand in MTH313. A
comparison between the apo and salicylate complex of
MTH313 revealed a signiﬁcant asymmetrical conforma-
tional change that is mediated by the binding of sodium
salicylate to two distinct locations in the dimer (21),
whereas we did not observe such changes in the case of
ST1710. The available in vivo and in vitro analyses suggest
that the MarR family of regulators inhibits the activity in
the presence of salicylate. Since we could see only the ﬁxed
side-chain orientation of the protein residues contacting
the bound salicylate ligand, we believe possible dynamic
or allosteric changes occurring upon salicylate binding
to ST1710 to inhibit its activity would not be captured
by crystallization.
Overall structure of the ST1710–DNA operator complex
In our earlier studies, we identiﬁed the putative promoter
for ST1710, which is located upstream of the st1710
gene (13). The gel-mobility shift analysis suggested that
protein–DNA interactions were competitive and concen-
tration dependent (Supplementary Figure S2). Here, we
complexed the ST1710 and 30-mer duplexed DNA
(Figure 3A), crystallized, and collected the data set up to
a resolution of 2.1A ˚ , under the space group C2221.
Initially, we were unsuccessful in solving the structure by
molecular replacement using the coordinates of our native
structure. Later, we solved the ST1710–DNA complex by
the MAD method using three diﬀerent data sets collected
at the Se-edge, and the structure was reﬁned to a ﬁnal R
value of 23.7% and an Rfree value of 28.7%. A high qual-
ity electron density map enabled us to build the nucleic
acids unambiguously (Figure 3B). The overall structure of
ST1710–DNA complex is shown in Figures 3C–E. The
protein crystallized as a dimer in the asymmetric unit
(asu) with the DNA fragment bound to one of the dimeric
molecules (Figure 3C). Part of the packing diagram with
two and four asymmetric unit of the molecules related by
the crystallographic 2-fold axis is also given (Figures 3D
and E). The duplex-DNA fragments observed in two adja-
cent asu of the dimeric molecules shown in magenta and
red (Figure 3E), probably form one double-stranded DNA
molecule of the full-length promoter DNA. The full-length
(30-mer) of the DNA-duplex in the crystals were also con-
ﬁrmed by dissolving the complex crystals (ST1710–DNA)
in water, after washing them a few times in reservoir solu-
tion, and then analyzed DNA-duplex, using agarose gel
electrophoresis. These analyses indicated that the DNA-
duplex present in the crystal was, indeed, the full-length
DNA (Supplementary Figure S3). To clarify further the
DNA binding to ST1710, we prepared an additional DNA
duplex with exactly 2-fold related sequence based on the
observed fragments in the present crystal (50-TTGCTATT
GTTAACAATAGCAAAAAT-30) (Figure 3A, bottom
sequence), crystallized, and solved the structure. The over-
all structure of this new complex resembles the present
one, and it recognizes the DNA fragment irrespective of
the sequence heterogeneity (our unpublished data). As
shown in Figure 3E, one full-length duplex-DNA was
interacted with four molecules of the ST1710, which was
coming from four diﬀerent asu of the dimeric molecules.
Thus, the analysis of the ST1710–DNA complex in the
present study suggests that the protein:DNA ratio is 2:1.
Interestingly, the bound DNA passes over the wHtH
motif, making contacts only at the loop regions.
Interactions between the ST1710 and promoter DNA
As explained above, Figure 4A represents the full length
duplex-DNA bound to four monomers of the symmetry-
related dimeric molecules. Although we used only a
30-mer duplexed DNA for our crystallization studies, we
could see the duplexed-DNA consisting of T5 to A27 and
T50 to A270 of the bases bound to the protein (Figures 4A
and B). The 4 and 3 bases at the 50- and 30-end, respec-
tively, were highly disordered in both of the DNA-strands
and hence not modeled. The bound DNA adapted a
B-form right handed structure, passing over the protein
molecule by only contacting at the wHtH loop regions.
The protein–DNA interactions seen in the asu of the
complex (Figures 3B and C) were essentially same in all
of the four symmetry-related molecules. Interestingly, as
observed in the OhrR-ohrA operator complex, the –10
region (TAACAAT) of the promoter DNA (15–21) was
recognized by the wHtH domains (Figures 4B–F). Of the
bound 54 nucleotides, only 22 nucleotides make 36 con-
tacts with six protein residues (Figures 4B–F). The side
chain oxygen of S65 was bonded to the O5
0 of Thy5
0.
Interestingly, the side chain (NH1) of residue R84 formed
water-mediated hydrogen bonds to the N3 of bases G13
0
and Ade17. In addition, side chain (NH1)o fR 89 hydrogen
bonded to the backbone phosphate oxygen (O2P) of
Thy14
0. The residue R90 hydrogen bonded to the O4
0 and
O2 of base Cyt18 and the same residue made two salt-
bridge contacts with D88. This salt bridge may assist in
ﬁxing the conformation of residue R90 in order to make
contact with the nucleic acid base, Cyt18. Besides, the side
chain atom (CD) bonded to the bases of Gua130 (N2) and
Thy140 (O2). The side chain of K91 interacted with back-
bone phosphate of Ade19 and Ile91 to C5 of Ade20. Thus,
the following residues S65,R 84,D 88,R 89,R 90,K 91 and I92
interacted with the bound promoter DNA. To evaluate
the protein–DNA interactions at the loop region,
4728 Nucleic Acids Research, 2009, Vol. 37,No. 14Figure 3. Structure of ST1710–DNA complex. (A) DNA sequence used for crystallization (30-mer and 26-mer duplex). The blue background shows
the 2-fold related sequence. The red boxed residues were observed in the crystal structure. (B) The ﬁnal 2Fo-Fc omit electron density map with the
nucleic acids contoured at 1s level is shown in blue mesh. The template strand and its complementary strands are shown in blue and yellow stick
models. (C) Stereo view of the asymmetric unit of ST1710–DNA complex. The secondary structural assignments, N- and C-terminal ends are labeled
in one of the dimeric monomers. The bound nucleic acids are shown as stick representations. (D) Stereo view of the two dimers of the asymmetric
unit related by 2-fold axis to form the tetramer for recognition of one promoter DNA. (E) Part of the crystal packing is shown (stereo view). Each
asymmetric unit of the complex is shown in a unique color. The 50- and 30- ends of each nucleotide chain is labeled.
Nucleic Acids Research, 2009,Vol.37, No. 14 4729Figure 4. ST1710–promoter DNA interactions. (A) A ribbon diagram of ST1710–DNA complex colored as in Figure 4E. The full-length promoter
DNA is shown in stick model. The T5-A27 and T50-A270 strands are in blue and yellow, respectively. (B) Schematic representation showing all
ST1710–DNA contacts. The bases are shown in rectangles. The protein–DNA contacts in each of the ST1710 monomer are represented by the same
color in (A). (C–F) The close-up view of the critical protein–DNA interactions in the complex is shown in A–D. The residues of nucleic acids and
protein are shown in stick models. The hydrogen bonds are shown in broken lines.
4730 Nucleic Acids Research, 2009, Vol. 37,No. 14we prepared three mutant proteins (R89A, R90A and
K91A) and analyzed the binding ability by gel-mobility
shift assays. All three mutants failed to bind to DNA,
suggesting that these three residues are important for pro-
tein–DNA interactions (Supplementary Figure S4). We
also crystallized all three mutant proteins under the
native protein conditions and solved their structures by
molecular replacement method as explained previously
(Table 1). All three mutant structures resembled the
native ST1710, except very little changes were observed
in the wHtH loop regions (Supplementary Figure S5).
Furthermore, DNA-binding residues in ST1710 were
highly conserved among the closely related proteins and
OhrR (Figure 2E). The winged loop region connecting
the strands b1 and b2 apparently plays a major role in
modulating their conformation for binding to the DNA
molecule, and this mode of recognition is anticipated for
the proteins closely related to ST1710 as well as the family
of MarR regulators. We observed Ca
2+ ions in all of the
mutant and native structures, but not in the salicylate and
DNA-complex structures. Superimposition of the native,
salicylate and DNA-complex structures suggested that the
C-terminal helix (a6) in the DNA complex deviated greatly
from the metal ion binding site and in the salicylate com-
plex slight changes in side chain orientations were observed
(Supplementary Figure S6). However, the functions of this
metal ion observed in the native and mutant structures of
ST1710 will need to be further investigated.
Conformational changes
In our recent report, we noticed a small change only at the
loop region connecting strands b1 and b2 in the protein
conformers crystallized in two diﬀerent space groups and
the overall structure was identical with an rmsd of 0.519A ˚
for 141 Ca atoms (13). In a similar way, when we com-
pared the present ST1710–salicylate complex and native
structure crystallized under the same conditions, a similar
structural conformation was revealed with an rmsd of
0.11A ˚ for superposition of 141 Ca atoms. Additionally,
the subunits in the dimer were identical. In contrast, the
superimposition of the ST1710–DNA complex subunits
(A and B chains) on one another revealed a large local
conformational change all along the structure, excluding
the helices a1 and a5 with an rmsd of 2.85A ˚ for 142 Ca
atoms; however, the overall structural topology was sim-
ilar (Figure 5A). A displacement of  3.5–5.5A ˚ was seen
all along the winged HtH motif region and the C-terminal
helix showed the displacement of around 2–3A ˚ . The
winged HtH motif of A-chain where the DNA is recog-
nized was elevated up compared to the B-chain, while the
C-terminal helix a6 was shifted down.
As seen in Figure 5B, signiﬁcant changes were also
observed between the subunits of the DNA-complex and
the native and salicylate complex. Superposition of the
native and salicylate complexes on to the A-chain
showed greater diﬀerences than on the B-chain: an rmsd
of 2.6 and 2.9A ˚ with the A-chain; and 0.9 and 1.0A ˚ with
the B-chain, for the native structure and salicylate com-
plex, respectively. One of the wHtH motifs may have been
relocated to establish contact with the DNA, and by this
mode of recognition, the wHtH loop regions were stabi-
lized. The temperature factor for this loop region in the
B-chain increased signiﬁcantly, although it formed a dimer
related by a non-crystallographic 2-fold axis, observed in
the asymmetric unit of the cell (Supplementary Figure S7).
It is noteworthy to mention that the temperature factor
was higher for the DNA-complex B-chain when not only
compared to the DNA-complex A-chain, but also to the
native, salicylate complex and all three of the mutant
structures. Apparently, when protein binds to the DNA,
the wHtH loop becomes stabilized and the temperature
factor of that region is lowered; this observation was sim-
ilar to that of the salicylate-complex which was solved at
the highest resolution. It is also interesting to note that
in the dimer, the distances between the loop to loop
(connecting the b-strands) of the wHtH domains were
reduced by  10A ˚ for the ST1710–DNA complex, com-
pared to the native and salicylate complexes.
Mode of nucleic-acid binding
There are several MarR families of regulators reported
to date from diﬀerent organisms including E. coli
(15), P. aeruginosa (16), S. aureus (17), E. faecalis (18),
B. subtilis (19), D. radiodurans (20) and M. thermoautotro-
phicum (21). However, only the structure of OhrR from
B. subtilis is available with its promoter and revealed their
interactions. It is intriguing to compare our ST1710–DNA
complex with OhrR-ohrA operator binding to clarify the
binding mechanism. The superimposition of the ST1710–
DNA complex on the OhrR-ohrA operator revealed large
conformational changes, with an rmsd of 4.4A ˚ for 215 Ca
atoms when compared to ST1710 before binding to its
cognate promoter (rmsd 2.80 for 238 Ca atoms)
(Figures 6A and B). Compared to the ST1710–DNA com-
plex with its native structure and salicylate complex in the
previous section, we found a similar change in the protein
and unexpectedly found conformational changes in the
mode of DNA recognition also. In the OhrR-ohrA com-
plex, the distance between the subunits loop-to-loop was
around 67A ˚ and the recognition helix (a4) helix was
about 20A ˚ (Figure 6A), although the wings of the subu-
nits translocated about 16A ˚ compared to the structure of
reduced OhrR (19). The bound 2-fold related promoter
sequence recognized the protein wHtH loop-to-loop,
with substantial widening and deepening of the major
groove that resulted from insertion of the recognition
helix (a4) of the HtH motif. In contrast to this mode of
binding, the bound DNA in ST1710 passed over the
wHTH motif without deepening the structure through
the 2-fold axis, even though the protein contacting resi-
dues are highly conserved between these two proteins and
among the MarR family of regulators (Figures 2E, 4A and
6B). This unexpected mode of DNA-binding originated
due to the translocation of one of the subunits around
13A ˚ towards the 2-fold axis, reducing the distance
between the recognition helix of the subunits to 13A ˚
(Figures 6A and B). Thus, the DNA passing through the
2-fold axis deepening the recognition helices as observed
in OhrR-ohrA operator complex would be impossible for
that of ST1710.
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4732 Nucleic Acids Research, 2009, Vol. 37,No. 14In conclusion, this report describes the crystal structure
of ST1710 in three diﬀerent forms: apo-form, ST1710–
salicylate and ST1710–DNA complex. We showed that
the salicylate binding does not aﬀect the overall structure.
In addition we found that all the residues interacting with
salicylate ligand are highly conserved among the closely
related proteins. The ST1710 conformation changed dra-
matically upon binding to the DNA, and these changes
might be necessary for its recognition. Structural analyses
of the MarR family of regulators along with the bacterial
transcription regulators such as BmrR (40) and CRP (41)
and the eukaryotic transcription regulators like RFX1
(42) and histone H5 (43) suggested that orientations of
the wHTH motifs were similar despite having little diﬀer-
ences in loop lengths and its orientations (19). We believe
most of the regulators containing wHTH motifs are prone
to bind DNA through their acidic/basic residues located in
their wings. However, the mode of DNA recognition
depends on the subunit organization of the regulators as
observed in the MarR family of proteins (ST1710, MarR).
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Figure 5. Structural comparison of ST1710–DNA complex monomers with its native structure and salicylate complex. (A) Superimposition
of ST1710–DNA complex monomers. As shown in Figure 2C one monomer of the complex is shown in cyan and the other monomer is in red.
(B) The ST1710–DNA complex monomers superimposed with the ST1710 native structure and salicylate complex. The native structure and salicylate
complex are represented by orange and green, respectively.
Figure 6. Structural comparison of MarR family of protein–DNA complexes. Superposition of the OhrR-ohrA operator complex (PDB id, 1z9c) on
the ST1710–DNA complex is shown without (A) and with nucleic acids (B). The protein and nucleic acids are shown in ST1710–DNA complex in
cyan and green; while those in the OhrR-ohrA operator complex are shown in blue and red, respectively. The distances between the loop-to-loop and
recognition helices are marked in (A). The 50- and 30- ends of each nucleotide chain are labeled.
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